Biomerica (BMRA) Net Margin (2010 - 2026)

Biomerica has disclosed Net Margin across 17 years of filings, most recently posting 132.93% for Q1 2026.

• Net Margin for Q1 2026 came in at 132.93%, down 2900.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 96.49% (down 1255.0% YoY), and the FY2025 annual result was 93.64%, up 1521.0% from the prior year.
• Net Margin came in at 132.93% for Q1 2026 at Biomerica, down from 109.09% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 0.14% in Q3 2025 to a low of 206.14% in Q2 2025.
• The 5-year median for Net Margin is 109.09% (2025), against an average of 102.03%.
• Across the five-year window, Net Margin soared 12918 bps in 2022 and tumbled 14716 bps in 2023, its largest moves.
• Biomerica's Net Margin stood at 109.72% in 2022, then gained by 12 bps to 96.17% in 2023, then surged by 40 bps to 58.07% in 2024, then sank by 88 bps to 109.09% in 2025, then slipped by 22 bps to 132.93% in 2026.
• The last three Net Margin figures came in at 132.93% (Q1 2026), 109.09% (Q4 2025), and 0.14% (Q3 2025), per Business Quant data.